指南与共识慢阻肺

急性呼吸衰竭有创机械通气的适应证与替代方案:德国S3指南系统评价

Invasive mechanical ventilation: indications and alternatives : Systematic evaluation of the evidence and recommendations for clinical practice from the S3 guidelines "invasive mechanical ventilation and the use of extracorporeal procedures in acute respiratory failure"
RSS 订阅 · 指南共识 · 呼吸支持与睡眠 · 2026-06-24

本文总结德国S3指南中关于有创机械通气适应证解读与替代方案的章节,通过系统文献检索与证据到决策框架形成推荐。无创呼吸支持(NIV和HFNO)对PaO2/FiO2 100-300 mmHg的中度氧合障碍患者有效并可避免插管,但需密切监测;PaO2/FiO2<100 mmHg或非侵入性支持治疗失败时需要有创通气。

要点

  • PaO2/FiO2 100-300 mmHg的中度氧合障碍患者可用NIV或HFNO避免插管,但需密切临床监测。
  • PaO2/FiO2<100 mmHg或非侵入性呼吸支持治疗失败时,需要有创机械通气。
  • 呼吸支持方式的选择应个体化并纳入患者偏好,定期再评估并避免延迟插管。

核心结论

  • 现有证据支持在急性呼吸衰竭中选择呼吸支持方式时采取个体化方法,并纳入患者偏好。

研究设计与样本

  • 德国S3临床指南修订中,进行了系统文献检索与批判性评价,纳入国内和国际指南。
  • 推荐意见采用证据到决策框架制定,并经多次会议达成共识。

主要发现

  • 无创呼吸支持包括无创通气(NIV)和高流量鼻氧(HFNO),对PaO2/FiO2 100-300 mmHg的中度氧合障碍患者有效,可避免气管插管但需密切临床监测。
  • PaO2/FiO2<100 mmHg的严重呼吸衰竭患者或非侵入性呼吸支持治疗失败时,需要有创通气。
  • 指南还针对特定患者群体提出了进一步推荐。

关键数值与推荐

  • PaO2/FiO2 100-300 mmHg:无创呼吸支持(NIV或HFNO)有效,可避免气管插管,需密切临床监测。
  • PaO2/FiO2<100 mmHg:需要有创机械通气。
  • 非侵入性呼吸支持治疗失败:需要有创机械通气。

临床怎么用

  • 对中度氧合障碍(PaO2/FiO2 100-300 mmHg)患者可优先尝试NIV或HFNO,同时密切监测。
  • 对严重呼吸衰竭(PaO2/FiO2<100 mmHg)或非侵入性支持失败者应及时转为有创通气,避免延迟插管。
  • 呼吸支持选择应个体化并纳入患者偏好,定期再评估,确保人员和专家资源充足,并在跨学科团队内透明沟通。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Med Klin Intensivmed Notfmed. 2026 Jun 24. doi: 10.1007/s00063-026-01468-9. Online ahead of print. ABSTRACT BACKGROUND: Selecting the appropriate mode of respiratory support in cases of acute respiratory failure is clinically challenging and has relevant implications for patient outcomes. Despite the widespread use of noninvasive techniques, uncertainties remain regarding optimal indications, timing of escalation and patient-centered aspects. AIM OF THIS STUDY: This paper summarizes the chapter on interpretation of indications and alternatives to invasive mechanical ventilation from the German S3 clinical guidelines "invasive ventilation and extracorporeal life support in acute respiratory failure". METHODS: For the guideline revision a systematic literature search and critical appraisal were conducted, including national and international guidelines. Recommendations were developed using the evidence to decision framework and a consensus was reached in several conferences. RESULTS: Noninvasive respiratory support, including noninvasive ventilation (NIV) and high-flow nasal oxygen (HFNO), is effective in patients with moderate impairment of oxygenation (PaO 2 /FiO 2 100-300 mm Hg) and can avoid endotracheal intubation but requires close clinical monitoring. In patients with severe respiratory failure (PaO 2 /FiO 2 < 100 mm Hg) or treatment failure under noninvasive respiratory support, invasive ventilation is required. Further recommendations concern specific patient groups. DISCUSSION: The available evidence supports an individualized approach to the choice of respiratory support that incorporates patients' preferences. Key elements include a regular reassessment, avoidance of delayed intubation, adequate personnel and expert resources and transparent communication within the interdisciplinary treatment team. PMID: 42340446 | DOI: 10.1007/s00063-026-01468-9

来源:指南共识 · 呼吸支持与睡眠,查看原文。版权归原作者所有。

引用

  1. 指南共识 · 呼吸支持与睡眠:Invasive mechanical ventilation: indications and alternatives : Systematic evaluation of the evidence and recommendations for clinical practice from the S3 guidelines "invasive mechanical ventilation and the use of extracorporeal procedures in acute respiratory failure"

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。